Haemonetics Corporation (HAE)

NYSE · Healthcare · Medical Devices
$120.16-0.17%As of 2026-11-22 · USD
Last session low $119.68Last session high $122.00
52-week low $51.0052-week high $132.00
Market cap
$5.47B
Sector
Healthcare
P/E (TTM)
53.2x
Next earnings
2027-02-04 (est.)

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)52.1In the neutral range (30 to 70)
MACD (12, 26, 9)1.66Below its signal line (2.27); histogram -0.60
Bollinger %B (20, 2)39%Inside the bands (116.84 to 125.29)
SMA 20121.06Price is 0.7% below
SMA 50115.17Price is 4.3% above
SMA 20082.65Price is 45.4% above
ATR (20)3.31% of priceAverage true range per day
52-week position85%In the upper part of the 51.00 to 132.00 range

About Haemonetics Corporation

Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions. The company operates through Plasma, Blood Center, and Hospital segments.

Latest fiscal yearEnded 2026-03-31: revenue of $1.33B and an operating margin of 18.1%.
Next earnings reportExpected on 2027-02-04 (the date is an estimate).

More in Medical Devices